← All decks

Anaesthesiology

Monitored Anesthesia Care

Built from Barash Clinical Anesthesia, 9th Edition

What’s inside

11 sections · 194 slides

  1. 01

    Overview

    • What this topic covers
    • Definition of monitored anesthesia care
    • Focus of the anesthesiologist during MAC

    3 slides

  2. 02

    Terminology and Definitions

    • Monitored anesthesia care versus moderate sedation
    • Who may give moderate sedation
    • Standards applied to monitored anesthesia care
    • Services the anesthesiologist provides during MAC
    • Threshold at which care becomes a general anesthetic
    • ASA requirements for the MAC service
    • ASA statements, guidelines and advisories on MAC and sedation

    7 slides

  3. 03

    Preoperative Assessment

    • Scope of the preoperative evaluation
    • Medical conditions that raise risk during MAC
    • Airway assessment before MAC
    • Determinants of monitored anesthesia care candidacy
    • Patient conditions favouring general anesthesia
    • Patient motivation and communication
    • Three roles of verbal communication during MAC
    • Case factors in choosing monitored anesthesia care
    • Effect of long procedure duration
    • Fire risk from supplemental oxygen under drapes
    • Reasons for converting MAC to general anesthesia
    • Inability to tolerate monitored anesthesia care
    • Additional causes of conversion to general anesthesia
    • Setting patient expectations before MAC

    14 slides

  4. 04

    Monitoring during Monitored Anesthesia Care

    • Applicability of ASA basic monitoring standards
    • The provider as the primary monitor
    • Value of pulse oximetry
    • Mechanisms of respiratory compromise during MAC
    • Closed claims evidence supporting oxygen monitoring
    • Role of capnography during monitored anesthesia care
    • Nasal cannula with an integrated gas sampling port
    • Improvised end-tidal carbon dioxide sampling
    • Evidence that capnography detects respiratory events
    • Case for routine capnography in every MAC case
    • Cardiovascular monitoring requirements
    • Temperature monitoring during MAC
    • Thermoregulatory defenses and their impairment
    • Hyperthermia during monitored anesthesia care
    • Methods of assessing depth of sedation
    • The ASA continuum of depth of sedation
    • Minimal and moderate sedation defined
    • Deep sedation and general anesthesia defined
    • Ramsay Sedation Scale
    • Richmond Agitation Sedation Score
    • Observer's Assessment of Alertness/Sedation Scale
    • Modified Ramsay Sedation Scale against the ASA continuum
    • Richmond Agitation-Sedation Scale against the ASA continuum
    • Modified Observer’s Assessment of Alertness/Sedation Scale against the ASA continuum
    • Bispectral index monitoring during sedation
    • Limitations of the bispectral index
    • Drummond's criteria for a useful depth monitor

    27 slides

  5. 05

    Supplemental Oxygen and Airway Fires

    • Hypoxia from alveolar hypoventilation
    • Worked example of the alveolar gas equation in hypoventilation
    • Effect of raising inspired oxygen to 28%
    • Two lessons from the oxygen worked example
    • Evidence on routine supplemental oxygen during sedation
    • Leading cause of death and severe injury during MAC
    • Ingredients of a head and neck surgical fire
    • Measured effective inspired oxygen concentrations
    • Delivering sub-100% oxygen mixtures
    • Recommendations to prevent burn injuries during MAC

    10 slides

  6. 06

    Techniques and Pharmacologic Basis

    • Goals of drug administration during MAC
    • Verbal communication as a safety threshold
    • Targeted treatment of pain, anxiety and agitation
    • Life-threatening causes of patient agitation
    • Pharmacokinetic and pharmacodynamic variability
    • Principle of titration in small increments
    • Continuous infusion versus intermittent boluses
    • Drug concentration during different administration techniques
    • Distribution after intravenous administration
    • Accumulation in poorly perfused tissues
    • Limitations of elimination half-life
    • Definition of context-sensitive half-time
    • Context-sensitive half-time as a function of infusion duration
    • Rise in context-sensitive half-time with infusion duration
    • Fentanyl and sufentanil compared
    • Propofol and thiopental compared
    • Factors determining time to recovery
    • Effect-site concentration and awakening
    • Effect-site equilibration time
    • Comparative equilibration times of intravenous drugs
    • Bolus spacing to avoid inadvertent overdose
    • Rationale for combining drugs during MAC
    • Nature of anesthetic drug interactions
    • Cpss50 as a measure of intravenous drug potency
    • Clinical implications of the steep dose-response curve
    • Synergism between opioids and benzodiazepines
    • Respiratory consequences of midazolam with fentanyl

    27 slides

  7. 07

    Specific Drugs Used for MAC

    • Propofol as a sedative-hypnotic for MAC
    • Propofol compared with benzodiazepines
    • Propofol sedation as an adjunct to spinal anesthesia
    • Propofol versus midazolam as a spinal adjunct
    • Pain on injection of propofol
    • Most effective strategies against propofol injection pain
    • Published strategies for reducing pain on intravenous injection of propofol
    • Role of benzodiazepines during MAC
    • Midazolam in a modified balanced technique
    • Effect of age on benzodiazepine requirements
    • Recovery profile after benzodiazepine sedation
    • Reversibility as a safety margin
    • Recommended regimen for intravenous flumazenil to antagonize benzodiazepine effects
    • Remimazolam pharmacology
    • Remimazolam compared with midazolam
    • Remimazolam dosing and current evidence
    • Indications for opioids during monitored anesthesia care
    • Choosing and titrating an opioid
    • Time to peak effect after opioid bolus
    • Remifentanil pharmacology
    • Remifentanil kinetics compared with other opioids
    • Therapeutic end point for remifentanil
    • Midazolam co-administration with remifentanil
    • Practical remifentanil infusion regimen
    • Typical adult intravenous dose ranges of sedative, hypnotic and analgesic drugs
    • Typical adult intravenous dose ranges of sedative, hypnotic and analgesic drugs (continued)
    • Ketamine during monitored anesthesia care
    • Cautions with ketamine
    • Rationale for the ketamine-propofol combination
    • Evidence on respiratory events with ketofol
    • Ketofol ratios and dosing
    • Dexmedetomidine pharmacology
    • Dexmedetomidine sedation quality and dosing
    • Respiratory effects of dexmedetomidine
    • Clinical uses of dexmedetomidine during MAC
    • Dexmedetomidine for difficult airway instrumentation
    • Dexmedetomidine compared with propofol
    • Comparison of important properties of propofol and dexmedetomidine

    38 slides

  8. 08

    Complications during Monitored Anesthesia Care

    • Overall complication rate of monitored anesthesia care
    • Respiratory depression as the leading MAC complication
    • Collapsing tendency of the upper airway
    • Coordination of dilator and diaphragmatic activity
    • Sensitivity of dilator muscle control to sedation
    • Why the compensatory response fails
    • Patients most vulnerable to sedation-induced airway compromise
    • Effects of specific drug classes on ventilatory response
    • Impairment of protective airway reflexes
    • Recovery time of the swallowing reflex
    • Managing patients at high aspiration risk
    • Propofol and upper airway protective reflexes
    • Mechanism of laryngospasm
    • Motor response producing glottic closure
    • Persistence and consequences of true laryngeal spasm
    • Incidence and risk factors for laryngospasm
    • Limits of positive pressure ventilation in laryngospasm
    • Larson's maneuver
    • Definitive treatment of laryngospasm
    • Causes of hemodynamic instability during MAC
    • Managing cardiovascular risk during MAC
    • Preparedness for local anesthetic systemic toxicity
    • Mechanism and progression of local anesthetic toxicity
    • Effects of hypercarbia on local anesthetic toxicity
    • Masking of local anesthetic toxicity by sedation

    25 slides

  9. 09

    Closed Claims and Nonanesthesiologist Sedation

    • Trend in closed claims associated with MAC
    • Non-operating room anesthesia claims
    • Reasons nonanesthesiologists provide sedation
    • Indirect involvement of anesthesiologists
    • Core elements of the nonanesthesiologist sedation guidelines
    • Dedicated observer requirements
    • Education and training requirements
    • High-risk groups needing preprocedure consultation
    • Privileging for moderate and deep sedation
    • Qualifications required for deep sedation
    • CMS classification of anesthesia versus analgesia services
    • ASA statement on the safe use of propofol
    • Restriction on propofol, ketamine and etomidate

    13 slides

  10. 10

    Future Directions

    • Economic pressure on anesthesia-provided sedation
    • Patient-controlled sedation and analgesia
    • Target-controlled infusions
    • Closed loop anesthesia delivery systems
    • Limitations of closed loop systems
    • Machine learning and artificial intelligence in sedation

    6 slides

  11. 11

    Conclusion and Key Points

    • Growing demand for monitored anesthesia care
    • Key points on the nature of monitored anesthesia care
    • Key points on safety during monitored anesthesia care
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Barash, Cullen, and Stoelting's Clinical Anesthesia, 9th Edition

    14 slides